We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
Guidance for clinical trials that use Decentralised Manufactured Investigational Medicinal Products (IMPs).
Guidance for manufacturers of artificial heart valves. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Video series explaining the main changes introduced by the Windsor Framework on the supply of medicines in Northern Ireland.
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
Canada and UK Trade Continuity Agreement enters into force
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
Which submission type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
Briefing for local authorities on the increasing role of community pharmacy in public health, working with councils and other community partners.
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
Personal protective equipment for sale by the Department of Health and Social Care (DHSC) including visors, gowns, aprons and goggles.
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).